CRISPR/Cas9-Engineered HLA-Deleted Glomerular Endothelial Cells as a Tool to Predict Pathogenic Non-HLA Antibodies in Kidney Transplant Recipients.
Lamarthée B, Burger C, Leclaire C, Lebraud E, Zablocki A, Morin L, Lebreton X, Charreau B, Snanoudj R, Charbonnier S, Blein T, Hardy M, Zuber J, Satchell S, Gallazzini M, Terzi F, Legendre C, Taupin JL, Rabant M, Tinel C, Anglicheau D.
Lamarthée B, et al. Among authors: zablocki a.
J Am Soc Nephrol. 2021 Dec;32(12):3231-3251. doi: 10.1681/ASN.2021050689.
J Am Soc Nephrol. 2021.
PMID: 35167486
Free PMC article.